Mayo Clinic Hospital Florida

Jacksonville, Florida 32224-1865

3 studies enrolling now · 11 studies all time

What they study most

AL Amyloidosis, Advanced NET of GI Origin, Amyotrophic Lateral Sclerosis, Castrate-Resistant Prostate Cancer, Cirrhosis, Gastro-enteropancreatic Neuroendocrine Tumor, Liver Transplant, Multiple Myeloma, Myeloma, Myeloma Multiple, NASH - Nonalcoholic Steatohepatitis, Neuroendocrine (NE) Tumors

Studies at this site

• A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma — Recruiting now
• US National OCS Liver Perfusion (OLP) Registry — Recruiting now
• A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET — Running, not enrolling
• A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma — Running, not enrolling
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis — Stopped early
• AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study) — Starting soon
• Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) — Completed
• A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) — Completed
• A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis — Completed
• Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor — Completed
• Study in Subjects With Light Chain (AL) Amyloidosis — Stopped early